共 50 条
Nobilamides A-H, Long-Acting Transient Receptor Potential Vanilloid-1 (TRPV1) Antagonists from Mollusk-Associated Bacteria
被引:32
|作者:
Lin, Zhenjian
[1
]
Reilly, Christopher A.
[2
]
Antemano, Rowena
[4
]
Hughen, Ronald W.
[3
]
Marett, Lenny
[1
]
Concepcion, Gisela P.
[4
]
Haygood, Margo G.
[5
]
Olivera, Baldomero M.
[6
]
Light, Alan
[3
]
Schmidt, Eric W.
[1
,6
]
机构:
[1] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA
[3] Univ Utah, Dept Anesthesiol, Salt Lake City, UT 84112 USA
[4] Univ Philippines, Inst Marine Sci, Quezon City 1101, Philippines
[5] Oregon Hlth & Sci Univ, OGI Sch Sci & Engn, Dept Environm & Biomol Syst, Beaverton, OR 97006 USA
[6] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA
关键词:
CAPSAICIN RECEPTOR;
ION-CHANNEL;
CELL-DEATH;
EPITHELIAL-CELLS;
ACTIVATION;
SENSITIZE;
CYSTEINE;
TL-119;
ACIDS;
D O I:
10.1021/jm101621u
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
New compounds nobilamides A-H and related known compounds A-3302-A and A-3302-B were isolated based upon their suppression of capsaicin-induced calcium uptake in a mouse dorsal root ganglion primary cell culture assay. Two of these compounds, nobilamide B and A-3302-A, were shown to be long-acting antagonists of mouse and human TRPV1 channels, abolishing activity for >1 h after removal of drug presumably via a covalent attachment. Other derivatives also inhibited the TRPV1 channel, albeit with low potency, affording a structure-activity profile to support the proposed mechanism of action. While the activities were modest, we propose a new mechanism of action and a new site of binding for these inhibitors that may spur development of related analogues for treatment of pain.
引用
收藏
页码:3746 / 3755
页数:10
相关论文